Skip to main content

Dialysis Market to touch USD 177.56 Billion by 2027; Increasing Number of Renal Therapy Clinics Worldwide to Positively Impact the Market: Fortune Business Insights™

Pune, June 25, 2020 (GLOBE NEWSWIRE) — The global dialysis market size is projected to reach USD 177.56 billion by 2027, exhibiting a CAGR of 7.7% during the forecast period. Complications caused in the renal system by the COVID-19 infection is likely to spike the demand for dialysis during the current year, states Fortune Business Insights™ in its report, titled “Dialysis Market Size, Share & COVID-19 Impact Analysis, By Type (Products and Services), By Dialysis Type (Hemodialysis and Peritoneal Dialysis), By End User (Dialysis Centers & Hospitals and Home Care), and Regional Forecast, 2020-2027”. The COVID-19 infection, according to researchers at the Johns Hopkins University, has been affecting kidney function in patients, even among those who have no history of kidney disease or any underlying renal condition.The university’s preliminary reports found that around 30% of the coronavirus patients in New York and China suffered from moderate to severe kidney malfunction during their hospital stay. Unusually high protein levels in urine and abnormal blood work have been the indicators for kidney damage in COVID-19 patients. Furthermore, patients developing severe kidney problems are required to undergo dialysis treatments to prevent additional damage from the infection. Thus, the coronavirus pandemic is expected to boost the market growth throughout 2020.Market intelligence tailored in response with the on-going crisis created by the coronavirus;Assessment of support provided by governments at various levels to businesses most severely impacted by the COVID-19 pandemic; andAnalysis of the changing strategies of different companies operating in various sectors to this crisis.The above features can be accessed in the high-quality reports containing impact evaluation of the COVID-19 pandemic across industries that we are offering businesses.As per the report findings, the market value was at USD 90.33 billion in 2019. The report offers the following:Careful study of all the market segments;Detailed analysis of the factors driving and restraining the market;Comprehensive insights into the regional dynamics impacting the market; andIn-depth profiling and examination of the key market players and their various market strategies.   An Overview of the Impact of COVID-19 on this Market:The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
To get the short-term and long-term impact of COVID-19 on this Market.
Please visit: https://www.fortunebusinessinsights.com/dialysis-market-102367
Rising Preference for Kidney Transplantation to Hamper Market GrowthPatients around the world suffering from kidney disease or damage are showing an increasing inclination towards kidney transplantation. The Global Observatory on Donation and Transplantation reported that 84,347 kidney transplant procedures were performed across the globe, indicating a 5.5% rise from 2014 levels. Similarly, the US Government Information on Organ Donation and Transplantation estimated that there were over 116,000 patients on the national transplant waiting list in August 2017.This preference for transplantation over dialysis procedures is mainly on account of the promise of better quality life and lower risk of death in end-stage kidney disease patients. On the other hand, dialysis requires hours of treatment at hospital or a clinic; with patients reporting low blood pressure, nausea, and abdominal cramps after the procedure was completed. To avoid the inconvenience and pain caused by dialysis, kidney patients increasingly prefer getting a new kidney, which bodes well for the dialysis market growth.Regional AnalysisNorth America to Hold Dominating Position in the Market; Asia-Pacific to Offer Bright ProspectsHigh incidence of chronic kidney disease (CKD) and end-stage renal disease (ESRD) enabled North America to register a market size of USD 36.46 billion in 2019. In 2020, the region is expected to tighten its hold on the market share owing to the skyrocketing number of COVID-19 cases in the US, which is surging the demand for these services in the region.In Asia-Pacific, on the other hand, the market stands to benefit considerably on account of rising government funding in India and China to enhance access to renal care. For instance, China formulated specific regulations in 2016 to establish standards for managing hemodialysis centers in the country. The market in Europe is also anticipated to grow steadily owing to the robust healthcare infrastructure in the continent.Regulatory Backing to Novel Products to Encourage Innovation among PlayersDevelopment of innovative dialysis solutions has been the mainstay strategy of majority of the players in this market. These innovations are finding strong support from regulatory bodies such as the US Food and Drug Administration (FDA), which is further encouraging other players to invest in R&D and bring out unique solutions for kidney patients.Industry Developments:May 2020: Ireland-based medical device leader, Medtronic, clinched the De Novo clearance from the US FDA for its machine devised to provide continuous dialysis for critically ill children. The approval will allow doctors and physicians to deliver continuous renal replacement therapy (CRRT) to pediatric patients.October 2019: The US-based kidney care specialist, Fresenius Medical Care North America, received ‘breakthrough device’ designation from the US FDA for its new hemodialysis system. Still under development and incorporated with Endexo, the antithrombogenic additive, the new device is designed to blood clotting in patients without using blood thinners.
List of Leading Companied Covered in the Dialysis Market Research Report are:

Nipro CorporationMedtronicBecton, Dickinson and CompanyB. Braun Melsungen AGFresenius Medical Care AG & Co. KGaAAsahi Kasei CorporationDiaverum Healthcare PartnersBaxter International, Inc.DaVita Healthcare Partners, Inc.
Have Any Query? Ask Our Experts:
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/dialysis-market-102367
IntroductionResearch ScopeMarket SegmentationResearch MethodologyDefinitions and AssumptionsExecutive SummaryMarket DynamicsMarket DriversMarket RestraintsMarket OpportunitiesKey InsightsRecent Industry Developments Such as Mergers & AcquisitionsStatistics on Prevalence of Chronic Kidney Disease (CKD) Across Key CountriesRegulatory Scenario for Key CountriesIndustry Background Pertaining to Dialysis Products and ServicesKey Industry TrendsNew Product LaunchGlobal Dialysis Market Analysis, Insights and Forecast, 2016-2027Key Findings / SummaryMarket Analysis, Insights and Forecast – By TypeProductServicesMarket Analysis, Insights and Forecast – By Dialysis TypeHemodialysisPeritoneal dialysisMarket Analysis, Insights and Forecast – By End UserDialysis Centers & HospitalsHome careMarket Analysis, Insights and Forecast – By RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaTOC Continued….!!!

Request for Customization:
https://www.fortunebusinessinsights.com/enquiry/customization/dialysis-market-102367
Hemodialysis Services Market Size, Share and Global Trend By Type (Home-Based Hemodialysis, In-Centre Hemodialysis), and Geography Forecast till 2026Peritoneal Dialysis Market Size, Share and Global Trend By Product Type (CAPD, APD), Product (Cyclers, Fluids), End User (Home health care and Hospitals) and Geography Forecast till 2025Dialysis Equipment Market Size, Share and Global Trend By Dialysis Equipment Type (Hemodialysis Equipment, Peritoneal Dialysis Equipment), By End User (Dialysis Centers and Hospitals, Home Healthcare) and Geography Forecast till 2026Dialyzers Market Size, Share and Global Trend by Flux Type (High-flux, Low-Flux), By Usage Type (Disposable, Reusable), By End User (Dialysis Centers and Hospitals, Home Healthcare), and Geography Forecast till 2026Hemodialysis Bloodline Systems Market Size, Share and Global Trend by Product Poly Vinyl, Chloride (Pvc) Haemodialysis Bloodline Systems, Polyethylene (Pvc) Haemodialysis Bloodline Systems, Polypropylene (Pp) Hemodialysis Bloodline Systems, ABS Hemodialysis bloodline systems), By Therapy Type (Double Needle Therapy, Single Needle Therapy, Single Needle), By End User (Hospitals, Clinics, Home Care Settings), and Geography Forecast till 2026
Hemodialysis Equipment Market Size, Share and Industry Analysis By Product (Hemodialysis Machines, Hemodialysis Consumables), By End User (Dialysis Centers & Hospitals, Home Healthcare) and Regional Forecast, 2018 – 2025
Vascular Grafts Market Size, Share and Global Trend By Product Type (Endovascular Stent Graft, Hemodialysis Access Graft, Bypass Graft, Peripheral Vascular Graft), By Application (Coronary Artery Disease, Vascular Occlusion, Renal Failure), By Material (Synthetic, Biological), By End User (Hospitals, Specialty Clinics), and Geography Forecast till 2026

About Us:
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune – 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs
Press Release: https://www.fortunebusinessinsights.com/press-release/dialysis-market-9627

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.